Literature DB >> 26797122

A Systematic Investigation of Structure/Function Requirements for the Apolipoprotein A-I/Lecithin Cholesterol Acyltransferase Interaction Loop of High-density Lipoprotein.

Xiaodong Gu1, Zhiping Wu1, Ying Huang1, Matthew A Wagner1, Camelia Baleanu-Gogonea1, Ryan A Mehl2, Jennifer A Buffa1, Anthony J DiDonato1, Leah B Hazen1, Paul L Fox1, Valentin Gogonea3, John S Parks4, Joseph A DiDonato1, Stanley L Hazen5.   

Abstract

The interaction of lecithin-cholesterol acyltransferase (LCAT) with apolipoprotein A-I (apoA-I) plays a critical role in high-density lipoprotein (HDL) maturation. We previously identified a highly solvent-exposed apoA-I loop domain (Leu(159)-Leu(170)) in nascent HDL, the so-called "solar flare" (SF) region, and proposed that it serves as an LCAT docking site (Wu, Z., Wagner, M. A., Zheng, L., Parks, J. S., Shy, J. M., 3rd, Smith, J. D., Gogonea, V., and Hazen, S. L. (2007) Nat. Struct. Mol. Biol. 14, 861-868). The stability and role of the SF domain of apoA-I in supporting HDL binding and activation of LCAT are debated. Here we show by site-directed mutagenesis that multiple residues within the SF region (Pro(165), Tyr(166), Ser(167), and Asp(168)) of apoA-I are critical for both LCAT binding to HDL and LCAT catalytic efficiency. The critical role for possible hydrogen bond interaction at apoA-I Tyr(166) was further supported using reconstituted HDL generated from apoA-I mutants (Tyr(166) → Glu or Asn), which showed preservation in both LCAT binding affinity and catalytic efficiency. Moreover, the in vivo functional significance of NO2-Tyr(166)-apoA-I, a specific post-translational modification on apoA-I that is abundant within human atherosclerotic plaque, was further investigated by using the recombinant protein generated from E. coli containing a mutated orthogonal tRNA synthetase/tRNACUA pair enabling site-specific insertion of the unnatural amino acid into apoA-I. NO2-Tyr(166)-apoA-I, after subcutaneous injection into hLCAT(Tg/Tg), apoA-I(-/-) mice, showed impaired LCAT activation in vivo, with significant reduction in HDL cholesteryl ester formation. The present results thus identify multiple structural features within the solvent-exposed SF region of apoA-I of nascent HDL essential for optimal LCAT binding and catalytic efficiency.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  LCAT; apolipoprotein; atherosclerosis; cholesterol; high-density lipoprotein (HDL); post-translational modification (PTM)

Mesh:

Substances:

Year:  2016        PMID: 26797122      PMCID: PMC4813583          DOI: 10.1074/jbc.M115.696088

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Significance of the hydrophobic residues 225-230 of apoA-I for the biogenesis of HDL.

Authors:  Panagiotis Fotakis; Ioanna Tiniakou; Andreas K Kateifides; Christina Gkolfinopoulou; Angeliki Chroni; Efstratios Stratikos; Vassilis I Zannis; Dimitris Kardassis
Journal:  J Lipid Res       Date:  2013-10-12       Impact factor: 5.922

Review 2.  Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literature.

Authors:  Bijan Roshan; Om P Ganda; Ranil Desilva; Rose B Ganim; Edmund Ward; Sarah D Haessler; Eliana Y Polisecki; Bela F Asztalos; Ernst J Schaefer
Journal:  J Clin Lipidol       Date:  2011-08-23       Impact factor: 4.766

3.  Characterization of C-terminal histidine-tagged human recombinant lecithin:cholesterol acyltransferase.

Authors:  J W Chisholm; A K Gebre; J S Parks
Journal:  J Lipid Res       Date:  1999-08       Impact factor: 5.922

4.  Activation of lecithin:cholesterol acyltransferase by HDL ApoA-I central helices.

Authors:  Mary G Sorci-Thomas; Shaila Bhat; Michael J Thomas
Journal:  Clin Lipidol       Date:  2009-02

5.  Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins.

Authors:  L Jin; J J Shieh; E Grabbe; S Adimoolam; D Durbin; A Jonas
Journal:  Biochemistry       Date:  1999-11-23       Impact factor: 3.162

6.  Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages.

Authors:  Lemin Zheng; Megan Settle; Gregory Brubaker; Dave Schmitt; Stanley L Hazen; Jonathan D Smith; Michael Kinter
Journal:  J Biol Chem       Date:  2004-10-21       Impact factor: 5.157

7.  Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional.

Authors:  Joseph A DiDonato; Kulwant Aulak; Ying Huang; Matthew Wagner; Gary Gerstenecker; Celalettin Topbas; Valentin Gogonea; Anthony J DiDonato; W H Wilson Tang; Ryan A Mehl; Paul L Fox; Edward F Plow; Jonathan D Smith; Edward A Fisher; Stanley L Hazen
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

Review 8.  Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.

Authors:  Eva Boes; Stefan Coassin; Barbara Kollerits; Iris M Heid; Florian Kronenberg
Journal:  Exp Gerontol       Date:  2008-11-17       Impact factor: 4.032

9.  Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I.

Authors:  Baohai Shao; Giorgio Cavigiolio; Nathan Brot; Michael N Oda; Jay W Heinecke
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

Review 10.  Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?

Authors:  Sandra Kunnen; Miranda Van Eck
Journal:  J Lipid Res       Date:  2012-05-07       Impact factor: 5.922

View more
  10 in total

1.  A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL.

Authors:  Allison L Cooke; Jamie Morris; John T Melchior; Scott E Street; W Gray Jerome; Rong Huang; Andrew B Herr; Loren E Smith; Jere P Segrest; Alan T Remaley; Amy S Shah; Thomas B Thompson; W Sean Davidson
Journal:  J Lipid Res       Date:  2018-05-17       Impact factor: 5.922

2.  A retractable lid in lecithin:cholesterol acyltransferase provides a structural mechanism for activation by apolipoprotein A-I.

Authors:  Kelly A Manthei; Joomi Ahn; Alisa Glukhova; Wenmin Yuan; Christopher Larkin; Taylor D Manett; Louise Chang; James A Shayman; Milton J Axley; Anna Schwendeman; John J G Tesmer
Journal:  J Biol Chem       Date:  2017-10-13       Impact factor: 5.157

3.  Efficient Site-Specific Prokaryotic and Eukaryotic Incorporation of Halotyrosine Amino Acids into Proteins.

Authors:  Hyo Sang Jang; Xiaodong Gu; Richard B Cooley; Joseph J Porter; Rachel L Henson; Taylor Willi; Joseph A DiDonato; Stanley L Hazen; Ryan A Mehl
Journal:  ACS Chem Biol       Date:  2020-02-10       Impact factor: 5.100

4.  The pattern of apolipoprotein A-I lysine carbamylation reflects its lipidation state and the chemical environment within human atherosclerotic aorta.

Authors:  Shawna Battle; Valentin Gogonea; Belinda Willard; Zeneng Wang; Xiaoming Fu; Ying Huang; Linda M Graham; Scott J Cameron; Joseph A DiDonato; John W Crabb; Stanley L Hazen
Journal:  J Biol Chem       Date:  2022-03-15       Impact factor: 5.486

5.  Molecular dynamics simulations of lipid nanodiscs.

Authors:  Mohsen Pourmousa; Richard W Pastor
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-05-03       Impact factor: 3.747

6.  Apolipoprotein C-III Nanodiscs Studied by Site-Specific Tryptophan Fluorescence.

Authors:  Chase A Brisbois; Jennifer C Lee
Journal:  Biochemistry       Date:  2016-08-23       Impact factor: 3.162

7.  Tertiary structure of apolipoprotein A-I in nascent high-density lipoproteins.

Authors:  Mohsen Pourmousa; Hyun D Song; Yi He; Jay W Heinecke; Jere P Segrest; Richard W Pastor
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-30       Impact factor: 11.205

8.  Interaction of lecithin:cholesterol acyltransferase with lipid surfaces and apolipoprotein A-I-derived peptides.

Authors:  Marco G Casteleijn; Petteri Parkkila; Tapani Viitala; Artturi Koivuniemi
Journal:  J Lipid Res       Date:  2018-02-08       Impact factor: 5.922

Review 9.  Systemic consequences of abnormal cholesterol handling: Interdependent pathways of inflammation and dyslipidemia.

Authors:  Ross O'Hagan; Alex R Berg; Christin G Hong; Philip M Parel; Nehal N Mehta; Heather L Teague
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

Review 10.  Potential Contribution of Short Chain Fatty Acids to Hepatic Apolipoprotein A-I Production.

Authors:  Herman E Popeijus; Willem Zwaan; Jehad Z Tayyeb; Jogchum Plat
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.